AHIP Submits Statement for Legislative Hearing on Drug Pricing Bills
posted by AHIP
on March 13, 2019
On March 13, 2019, AHIP submitted a statement for a legislative hearing on prescription drug pricing bills in the House Energy and Commerce Subcommittee on Health. Our statement expresses support for several bills on the hearing agenda—including the CREATES Act—that take important steps to reduce barriers to competition in the pharmaceutical marketplace.